Events & Presentations

Events & Presentations

Date Event Details Remind Me
Feb 12, 2020
Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of Directors
Feb 19, 2020
Publication of the Annual Report for 2019
Feb 19, 2020
6:00 PM CET
2019 Full Year Financial Results Conference Call

To join Genmab's Full Year 2019 Financial Results conference call, please dial one of the numbers below and provide the confirmation code 4887886:

Denmark: +45 32728042
UK: +44 2071 928000
USA: +1 631 510 7495
 

Mar 26, 2020
Annual General Meeting 2020
May 6, 2020
Publication of the Interim Report for the first quarter 2020 (after 5:00 PM CET)
Aug 12, 2020
Publication of the Interim Report for the first half 2020 (after 5:00 PM CET)
Nov 4, 2020
Publication of the Interim Report for the first nine months 2020 (after 5:00 PM CET)
Date Event Details
Jan 15, 2020
3:30 PM PST
38th Annual J.P. Morgan Healthcare Conference, San Francisco, CA, US
Dec 9, 2019
8:00 PM EST
2019 R&D Update and ASH Data Review
Nov 8, 2019
4:30 PM CET
Interactive Q&A Session with Genmab’s CEO
Nov 6, 2019
6:00 PM CET
First Nine Months of 2019 Financial Results Conference Call
Nov 6, 2019
Publication of the Interim Report for the first nine months 2019 (after 5:00 PM CET)
Aug 20, 2019
4:30 PM CEST
Interactive Q&A Session with Genmab's CEO
Aug 14, 2019
6:00 PM CEST
First Half 2019 Financial Results Conference Call
Aug 14, 2019
Publication of the Interim Report for the first half 2019 (after 5:00 PM CEST)
Jun 13 - Jun 16, 2019
24th European Hematology Association Annual Congress, Amsterdam, the Netherlands
May 31 - Jun 4, 2019
American Society of Clinical Oncology Annual Meeting, Chicago, IL, US
May 13, 2019
3:00 PM CEST
Interactive Q&A Session with Genmab's Senior Director, Investor Relations
May 8, 2019
6:00 PM CEST
First Quarter 2019 Financial Results Conference Call
May 8, 2019
5:00 PM CEST
Publication of the Interim Report for the first quarter 2019
Mar 29, 2019
Annual General Meeting 2019
Mar 4, 2019
4:00 PM CET
Interactive Q&A Session with Genmab's CEO
Feb 20, 2019
6:00 PM CET
2018 Full Year Financial Results Conference Call
Feb 20, 2019
5:00 PM CET
Publication of the Annual Report for 2018
Feb 14, 2019
Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of Directors
Jan 9, 2019
3:30 PM PST
37th Annual J.P. Morgan Healthcare Conference, San Francisco, CA, US